http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-220668-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_571b8abacacea64d3f7089d0983b8b3b |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C215-42 |
filingDate | 1990-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64bab70dd0497cfe84cc3801ad4654de |
publicationDate | 2002-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | HU-220668-B1 |
titleOfInvention | Enantiomeric purine derivatives and their preparation |
abstract | The present invention relates to the preparation of enantiomeric purine derivatives of general formula (Q) for the preparation of (I) generic purine nucleoside derivatives for the treatment of viral infections. In the formulas, A is (1S, 4R) - or (1R, 4S) -2-cyclopentene-1-methanol-4-yl, R is cyclopropylamino or halogen and R3 is C1-6alkanoyl. ŕ |
priorityDate | 1989-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 77.